These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 16500336

  • 21. Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
    de Kraker AT, Kenemans P, Smolders RG, Kroeks MV, van der Mooren MJ.
    Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):139-44. PubMed ID: 19095343
    [Abstract] [Full Text] [Related]

  • 22. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 23. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.
    Koh KK, Ahn JY, Jin DK, Yoon BK, Kim HS, Kim DS, Kang WC, Han SH, Choi IS, Shin EK.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1889-94. PubMed ID: 12933531
    [Abstract] [Full Text] [Related]

  • 24. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 25. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Eur Heart J; 2006 Mar 10; 27(6):746-55. PubMed ID: 16415304
    [Abstract] [Full Text] [Related]

  • 26. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
    Taner MZ, Ozpolat E, Taskiran C, Onan MA, Gursel T, Karabulut E, Gursoy R, Himmetoglu O.
    Maturitas; 2006 Feb 20; 53(3):267-73. PubMed ID: 15978753
    [Abstract] [Full Text] [Related]

  • 27. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study.
    Harden CL, Herzog AG, Nikolov BG, Koppel BS, Christos PJ, Fowler K, Labar DR, Hauser WA.
    Epilepsia; 2006 Sep 20; 47(9):1447-51. PubMed ID: 16981859
    [Abstract] [Full Text] [Related]

  • 28. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Creatsa MG, Economou EV, Siasou Z, Panoulis CP, Kalligerou I, Papadias C.
    Climacteric; 2008 Apr 20; 11(2):155-65. PubMed ID: 18365858
    [Abstract] [Full Text] [Related]

  • 29. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA, Fini M, Mercuro G, Rosano GM.
    Circulation; 2003 Jul 01; 107(25):3165-9. PubMed ID: 12796135
    [Abstract] [Full Text] [Related]

  • 30. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR, Women's Health Initiative Investigators.
    Obstet Gynecol; 2005 May 01; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [Abstract] [Full Text] [Related]

  • 31. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA, Wang ST, Pai MC, Chen CH, Wu MH, Huang KE.
    J Reprod Med; 2003 May 01; 48(5):375-80. PubMed ID: 12815913
    [Abstract] [Full Text] [Related]

  • 32. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V, Sangthawan M.
    J Med Assoc Thai; 2007 Sep 01; 90(9):1720-6. PubMed ID: 17957910
    [Abstract] [Full Text] [Related]

  • 33. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Sep 01; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 34. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C, Palacios S, Vázquez F, Villero J, Ferrer J, Ascaso C, Balasch J.
    Fertil Steril; 2007 Aug 01; 88(2):383-9. PubMed ID: 17561009
    [Abstract] [Full Text] [Related]

  • 35. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
    Chu MC, Cosper P, Nakhuda GS, Lobo RA.
    Fertil Steril; 2006 Dec 01; 86(6):1669-75. PubMed ID: 17074346
    [Abstract] [Full Text] [Related]

  • 36. Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
    Reuben DB, Palla SL, Hu P, Reboussin BA, Crandall C, Herrington DM, Barrett-Connor E, Greendale GA.
    Am J Med; 2006 Feb 01; 119(2):167.e1-8. PubMed ID: 16443423
    [Abstract] [Full Text] [Related]

  • 37. Effect of conjugated estrogen versus conjugated estrogen associated with medroxyprogesterone acetate in postmenopausal women on internal carotid artery pulsatility index: a randomized pilot study.
    Wender MC, Vigo F, Oliveira PP, Bittellbrun F, Furtado AP, Schvartzman L, Capp E, de Freitas FM.
    J Obstet Gynaecol Res; 2011 Jul 01; 37(7):815-8. PubMed ID: 21410828
    [Abstract] [Full Text] [Related]

  • 38. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
    Dedeoğlu EN, Erenus M, Yörük P.
    Fertil Steril; 2009 Feb 01; 91(2):425-31. PubMed ID: 18249383
    [Abstract] [Full Text] [Related]

  • 39. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H, Ichikawa S, Takahashi T, Sakamoto H, Goto-Onozato K, Koya S, Kanda T, Nara M, Seki K, Murakami M, Kurabayashi M.
    Maturitas; 2006 Feb 20; 53(3):306-14. PubMed ID: 16040211
    [Abstract] [Full Text] [Related]

  • 40. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA.
    Climacteric; 2005 Mar 20; 8(1):63-70. PubMed ID: 15804733
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.